2023
Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study
Tang G, Spencer J, Rogers T, Grubb K, Gleason P, Gada H, Mahoney P, Dauerman H, Forrest J, Reardon M, Blanke P, Leipsic J, Abdel-Wahab M, Attizzani G, Puri R, Caskey M, Chung C, Chen Y, Dudek D, Allen K, Chhatriwalla A, Htun W, Blackman D, Tarantini G, Sanchez J, Schwartz G, Popma J, Sathananthan J. Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study. Circulation Cardiovascular Interventions 2023, 16: e013238. PMID: 37988439, PMCID: PMC10653288, DOI: 10.1161/circinterventions.123.013238.Peer-Reviewed Original ResearchConceptsRedo-TAVRSAPIEN 3Coronary accessRedo transcatheter aortic valve replacementYounger low-risk patientsFuture coronary accessSAPIEN 3 valveAortic valve replacementLow-risk patientsSelf-expanding valvesPre-TAVR CTValve replacementValve implantationCT planningEvolutImplant positionTomography imagingPatientsCTNodes 4Implant depthTAVRSubstudyNodes 5ValveTCT-67 Comparison of In-Hospital Outcomes and 30-Day Readmission Rates Between Patients Who Underwent TAVR Versus SAVR for Aortic Stenosis in Liver Cirrhosis: A Propensity-Matched Analysis
Aggarwal A, Jang S, Vardhan S, Webber F, Lancaster G, Zarich S, Vora A, Elmariah S, Davila C. TCT-67 Comparison of In-Hospital Outcomes and 30-Day Readmission Rates Between Patients Who Underwent TAVR Versus SAVR for Aortic Stenosis in Liver Cirrhosis: A Propensity-Matched Analysis. Journal Of The American College Of Cardiology 2023, 82: b27. DOI: 10.1016/j.jacc.2023.09.072.Peer-Reviewed Original ResearchCor-Knot Use in SAVR Facilitates Coplanar Angle Adjustment During TAVR.
Hibino M, Palma Dallan L, Yoon S, Pelletier M, Ukaigwe A, Baeza C. Cor-Knot Use in SAVR Facilitates Coplanar Angle Adjustment During TAVR. Journal Of Invasive Cardiology 2023, 35: e108-e109. PMID: 36735874, DOI: 10.25270/jic/22.00156.Peer-Reviewed Original ResearchConceptsCOR-KNOTMinimally invasive cardiac surgeryPreoperative computed tomography scansInvasive cardiac surgeryAortic pressure gradientTrifecta valveCardiac surgeryAortic annulusConduction abnormalitiesParavalvular leakageRenal injuryTomography scanMm HgTAVR proceduresSurgical anatomyOperative timeTAVR valvesTAVRNext dayControl pacing
2022
C-55 | Feasibility of Impella-Assisted High-Risk PCI before TAVR in Patients with Severe Aortic Stenosis
Yeo I, Ko W, Kim L, Feldman D, Bergman G, Singh H, Reisman M, Jang S, Mick S, Iannacone E, Mack C, Wong S, Minutello R. C-55 | Feasibility of Impella-Assisted High-Risk PCI before TAVR in Patients with Severe Aortic Stenosis. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100207. DOI: 10.1016/j.jscai.2022.100207.Peer-Reviewed Original Research
2021
TCT-48 Incidence and Outcomes of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized Studies
Vora A, Gada H, Sherwood M, Lopes R, Forrest J, Huang J, Reardon M. TCT-48 Incidence and Outcomes of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized Studies. Journal Of The American College Of Cardiology 2021, 78: b19. DOI: 10.1016/j.jacc.2021.09.898.Peer-Reviewed Original ResearchApplicability of Transcatheter Aortic Valve Replacement Trials to Real-World Clinical Practice Findings From EXTEND-CoreValve
Butala NM, Secemsky E, Kazi DS, Song Y, Strom JB, Faridi KF, Brennan JM, Elmariah S, Shen C, Yeh RW. Applicability of Transcatheter Aortic Valve Replacement Trials to Real-World Clinical Practice Findings From EXTEND-CoreValve. JACC Cardiovascular Interventions 2021, 14: 2112-2123. PMID: 34620389, PMCID: PMC8855223, DOI: 10.1016/j.jcin.2021.08.006.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacement (TAVR) trialsReal-world patientsReal-world populationTrial patientsPivotal trialsClinical practiceTreatment effectsReplacement trialsAbsolute reductionClinical practice findingsU.S. clinical practiceCharacteristics of patientsCongestive heart failureTrial treatment effectPatient characteristicsTrial cohortHeart failureMedicare cohortAbsolute benefitConventional therapyClinical trialsInverse probability weightingMedicare patientsTAVRMedicare beneficiariesIMPACT OF PACEMAKER IMPLANT ≤ 30 DAYS POST TAVR ON MORTALITY: RESULTS OF A SINGLE CENTER PROSPECTIVE REGISTRY
See C, Wang Y, Yang Y, Tirziu D, Papoutsidakis N, Kaple R, Cleman M, Lansky A, Forrest J. IMPACT OF PACEMAKER IMPLANT ≤ 30 DAYS POST TAVR ON MORTALITY: RESULTS OF A SINGLE CENTER PROSPECTIVE REGISTRY. Journal Of The American College Of Cardiology 2021, 77: 974. DOI: 10.1016/s0735-1097(21)02333-0.Peer-Reviewed Original ResearchEffect of institutional transcatheter aortic valve replacement volume on mortality: A systematic review and meta‐analysis
Kir D, Shapero K, Chatterjee S, Grimshaw A, Oddleifson A, Spatz ES, Goldsweig AM, Desai NR. Effect of institutional transcatheter aortic valve replacement volume on mortality: A systematic review and meta‐analysis. Catheterization And Cardiovascular Interventions 2021, 98: e453-e461. PMID: 33565695, DOI: 10.1002/ccd.29502.Peer-Reviewed Original ResearchConceptsLow-volume centersVolume centersTitles/abstractsPatient outcomesTAVR centersTAVR volumeCause mortalitySystematic reviewHigh-volume centersIntermediate-volume centersReplacement volumeFull-text studiesCause mortality dataStrong referral networkFree-text termsSystematic literature searchPre-specified criteriaEligible studiesProcedural volumeExclusion criteriaMortality rateTAVRLiterature searchMortality dataRelevant articles
2020
Valve-in-Valve Transcatheter Aortic Valve Replacement: A Review of Procedural Details, Safety, and Clinical Implications.
Hameed I, Ahmed A, Ullah N, Salemi A. Valve-in-Valve Transcatheter Aortic Valve Replacement: A Review of Procedural Details, Safety, and Clinical Implications. Cardiology In Review 2020, 28: 291-294. PMID: 32947481, DOI: 10.1097/crd.0000000000000318.Peer-Reviewed Original ResearchConceptsAortic valve replacementValve transcatheter aortic valve replacementTranscatheter aortic valve replacementVIV-TAVRValve replacementYounger patientsClinical implicationsSurgical aortic valve replacementProcedural detailsHigh-risk patientsBioprosthesis implantationCoronary obstructionSurgical interventionValvular thrombosisBioprosthetic valvesResidual gradientPatientsAnecdotal experienceTAVRPreferred procedureLong-term dataSafetyReinterventionThrombosisPrognosisImpact of Operator Characteristics on Outcomes in Transcatheter Aortic Valve Replacement
Rong LQ, Gaudino M, Tam D, Mao J, Zheng X, Hameed I, Khan F, Salemi A, Sedrakyan A, Neuburger PJ, Fremes S. Impact of Operator Characteristics on Outcomes in Transcatheter Aortic Valve Replacement. The Annals Of Thoracic Surgery 2020, 111: 853-860. PMID: 32795521, DOI: 10.1016/j.athoracsur.2020.06.018.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementTranscatheter aortic valve replacement (TAVR) proceduresAortic valve replacement proceduresAortic valve replacementAcute myocardial infarctionHealth Statewide PlanningValve replacement proceduresOperator characteristicsInhospital outcomesTAVR volumeInhospital mortalityValve replacementPrimary outcomeMyocardial infarctionSubgroup analysisStatewide PlanningProvider characteristicsCardiology practiceNew York State DepartmentInterventional cardiologyTAVROperator specialtyReplacement proceduresMedical school locationSignificant differences
2019
Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations
Siddique S, Gada H, Mumtaz M, Vora A. Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations. Current Cardiology Reports 2019, 21: 161. PMID: 31781976, DOI: 10.1007/s11886-019-1250-5.Peer-Reviewed Original ResearchConceptsLow-risk patientsComposite endpoint of deathEndpoint of deathOptimal treatment choiceRandomized studyComposite endpointNon-inferior to surgeryTreatment choiceLow surgical risk patientsSurgical risk patientsPARTNER 3 trialSymptomatic aortic stenosisSymptomatic ASLack of long-term dataAortic stenosisFDA indicationRisk patientsPacemaker implantationValve deteriorationAnatomical factorsSummaryRecent trialsTAVRPatientsHigher incidenceProcedural considerationsEffect on 30-Day Readmissions after Early Versus Delayed Discharge after Uncomplicated Transcatheter Aortic Valve Implantation (from the Nationwide Readmissions Database)
Omer MA, Smolderen K, Kennedy K, Elgendy IY, Kolte D, Jones PG, Spertus JA, Arnold SV. Effect on 30-Day Readmissions after Early Versus Delayed Discharge after Uncomplicated Transcatheter Aortic Valve Implantation (from the Nationwide Readmissions Database). The American Journal Of Cardiology 2019, 125: 100-106. PMID: 31735327, DOI: 10.1016/j.amjcard.2019.09.040.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve implantationAortic valve implantationEarly dischargeReadmission ratesValve implantationChronic conditionsUncomplicated Transcatheter Aortic Valve ImplantationNational Readmission DatabasePropensity-matched cohortRisk of readmissionSingle-center studyBroad clinical practiceEarly VersusPatient characteristicsPatient factorsClinical practiceLate dischargeUS hospitalsReadmissionTAVRCohortDischarge strategyHigh rateSimilar ratesImplantationCardiac Biomarkers in Transcatheter Aortic Valve Implantation
Hermany P, Forrest J. Cardiac Biomarkers in Transcatheter Aortic Valve Implantation. 2019, 147-164. DOI: 10.1007/978-3-030-05912-5_13.Peer-Reviewed Original ResearchAortic valve replacementValve replacementMyocardial injuryCardiac proceduresCardiac biomarkersTranscatheter aortic valve implantationTranscatheter aortic valve replacementAortic stenosis managementSevere aortic stenosisAortic valve implantationCardiac biomarker releaseStandard of careAppropriate clinical applicationValve implantationAortic stenosisSuch patientsHemodynamic alterationsAdverse outcomesBiomarker releaseCardiac conditionsTAVRNovel markerPatientsCardiac physiologyBiomarkers
2014
Imaging and Functional Testing to Assess Clinical and Subclinical Neurological Events After Transcatheter or Surgical Aortic Valve Replacement A Comprehensive Review
Spaziano M, Francese DP, Leon MB, Généreux P. Imaging and Functional Testing to Assess Clinical and Subclinical Neurological Events After Transcatheter or Surgical Aortic Valve Replacement A Comprehensive Review. Journal Of The American College Of Cardiology 2014, 64: 1950-1963. PMID: 25444149, DOI: 10.1016/j.jacc.2014.07.986.Peer-Reviewed Original ResearchConceptsSurgical aortic valve replacementAortic valve replacementNeurological eventsValve replacementFuture comparative trialsFuture prospective studiesProspective studyPoor prognosisComparative trialsSubclinical cognitive declineSurrogate endpointsCognitive declineTesting modalitiesTAVRTranscatheterOperator experienceModalitiesFunctional testingImagingPrognosisClinicalSymptomsIncidenceComprehensive reviewEndpoint
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply